Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification
- Conditions
- CataractPosterior Capsule Opacification
- Registration Number
- NCT02445274
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
In this study, the investigators introduce a new "capsule-reserved" cataract surgical procedure in which anterior lens capsule is reserved and attached onto posterior lens capsule in the purpose of preventing posterior capsule opacification (PCO). A prospective randomized controlled study is reported to compare the new "capsule-reserved" surgical procedure with conventional one on the effectiveness to prevent posterior capsule opacification in age-related cataract patients.
- Detailed Description
A prospective, randomized controlled study of 240 eligible patients will been enrolled. Two eyes of each patient were assigned randomly to two groups respectively: Group I; anterior lens capsule is conventionally not reserved after continuous curvilinear capsulorhexis, while in Group II, anterior lens capsule is innovatively reserved and attached onto posterior lens capsule. This novel adjusted surgical procedure, featured by using the reserved anterior lens capsule to protect the peri-capsule microenvironment and prevent PCO, is conceptual different from the traditional cataract surgical procedure. Clinical examinations including posterior capsule opacification grading score, central posterior capsule thickness, central posterior capsule density, best corrected visual acuity, contrast sensitivity were carried out preoperatively and at each postoperative visit.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 240
- Aged 50 years or above
- Both eyes were diagnosed with age-related cataract
- Both eyes were planed to undergo the "Phacoemulsification and IOL implantation" surgery with 1 month
- Biocular BCVA improvement post surgery was feasible judged by the ophthalmologists.
- Other ocular diseases
- ACD<3CT
- Combined cataract surgery (trabeculoplasty, keratoplasty)
- Lens pseudoexfoliation syndrome combined with glaucoma or zonular abnormalities
- Previous intraocular surgery or trauma (laser not included)
- Uveitis
- Recent ocular infection
- Proliferative diabetic retinopathy
- Diabetes mellitus
- Congenital ocular abnormalities (aniridia, congenital cataract)
- Atrophy of iris
- Participants with previous clinical trials 30 days before surgery
- Using prostanoid eye drops
- Uncontrolled systematic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from Baseline in posterior capsule opacification grading score post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, Posterior capsule opacification(PCO)was recorded by standardized slit lamp retroillumination images and analyzed using the EPCO2000 program. The severity of PCO was clinically graded from 0 (none) to 4 (severe)
- Secondary Outcome Measures
Name Time Method Change from Baseline in central posterior capsule thickness post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1 Central posterior capsule thickness was recorded and calculated by Pentacam HR system
Change from Baseline in central posterior capsule density post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1 Central posterior capsule density was recorded and calculated by Pentacam HR system.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Zhognshan Ophthalmic Center, Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China
Zhognshan Ophthalmic Center, Sun Yat-sen University🇨🇳Guangzhou, Guangdong, ChinaHaotian Lin, M.D., Ph.D.Contact8613802793086haot.lin@hotmail.comJing Li, M.D.Contact+86-20-87330341Reviewborad_SYsU@163.com